# Vanguard Russell 2000 U.S. Small-Cap UCITS ETF (VRSG)

**Page:** https://fundology.uk/fund/vrsg · ISIN IE000GTBEXG4

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, VRSG (Vanguard Russell 2000 U.S. Small-Cap UCITS ETF, ISIN IE000GTBEXG4) closed at £70.75 on the London Stock Exchange. Its ongoing charge is 0.20% a year (about £20 on £10,000).

## Summary

Vanguard Russell 2000 U.S. Small-Cap UCITS ETF Accum Shs USD is an exchange-traded fund (ETF) from Vanguard, launched in 2026. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.2% a year — about £20 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£70.75** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | VRSG |
| ISIN | IE000GTBEXG4 |
| Also listed as | VRSA (London Stock Exchange, US dollars), V2SA (Xetra, euros) |
| Category | Smaller companies |
| Type | ETF |
| Provider | Vanguard |
| Income | Accumulating |
| Ongoing charge | 0.20% a year (£20 per £10,000) |
| Fund size | £11.1m |
| Launched | 2026 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 07/07/2026 |

## Charges compared with similar funds

Ongoing charge of Vanguard Russell 2000 U.S. Small-Cap UCITS ETF Accum Shs USD 0.20% a year. Compared on 14/11/2026, 32 of the 36 other smaller-company funds charge more, 0 the same and 4 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.20%** per year (as of 14/11/2026)
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 30/09/2026, VRSG holds 1,975 positions, according to its published holdings. The largest is Twist Bioscience at 0.43% of the fund; the ten largest make up 3.4%.

### Top holdings

Largest positions (as of 30/09/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Twist Bioscience | [TWST](https://fundology.uk/stock/TWST) | 0.43% |
| 2 | Moog | [MOG.A](https://fundology.uk/stock/MOG.A) | 0.37% |
| 3 | 10x Genomics | [TXG](https://fundology.uk/stock/TXG) | 0.36% |
| 4 | JFrog | [FROG](https://fundology.uk/stock/FROG) | 0.36% |
| 5 | BrightSpring Health Services | [BTSG](https://fundology.uk/stock/BTSG) | 0.32% |
| 6 | Glaukos | [GKOS](https://fundology.uk/stock/GKOS) | 0.32% |
| 7 | UMB Financial | [UMBF](https://fundology.uk/stock/UMBF) | 0.32% |
| 8 | ViaSat | [VSAT](https://fundology.uk/stock/VSAT) | 0.31% |
| 9 | CareTrust REIT | [CTRE](https://fundology.uk/stock/CTRE) | 0.30% |
| 10 | Cytokinetics | [CYTK](https://fundology.uk/stock/CYTK) | 0.30% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By sector

Added up from the fund’s published holdings, as of 30/09/2026.

| Sector | Weight |
|---|---|
| Health Care | 20.8% |
| Financials | 18.9% |
| Industrials | 14.0% |
| Information Technology | 13.7% |
| Consumer Discretionary | 8.8% |
| Energy | 6.7% |
| Real Estate | 5.7% |
| Materials | 4.2% |
| Other sectors | 7.1% |

### By country

Added up from the fund’s published holdings, as of 30/09/2026.

| Country | Weight |
|---|---|
| United States | 99.5% |
| Canada | 0.3% |
| Brazil | 0.1% |
| Singapore | 0.1% |

The 1,780 holdings on record (of 1,975 reported): https://fundology.uk/fund/vrsg/holdings

## Questions people ask

**What is the ongoing charge of VRSG?**

The ongoing charge of VRSG is 0.20% a year — about £20 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Vanguard Russell 2000 U.S. Small-Cap UCITS ETF Accum Shs USD 0.20% a year. Compared on 14/11/2026, 32 of the 36 other smaller-company funds charge more, 0 the same and 4 less (share classes counted once).

**Is VRSG accumulating or distributing?**

VRSG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of VRSG?**

The ISIN of VRSG is IE000GTBEXG4. An ISIN identifies one exact share class of a fund; VRSG is its ticker on the London Stock Exchange. The same share class is also listed as VRSA (London Stock Exchange, US dollars) and V2SA (Xetra, euros).

**What does VRSG hold?**

As of 30/09/2026, VRSG holds 1,975 positions, according to its published holdings. The largest is Twist Bioscience at 0.43% of the fund; the ten largest make up 3.4%. Its ten largest holdings are Twist Bioscience (0.43%), Moog (0.37%), 10x Genomics (0.36%), JFrog (0.36%), BrightSpring Health Services (0.32%), Glaukos (0.32%), UMB Financial (0.32%), ViaSat (0.31%), CareTrust REIT (0.30%) and Cytokinetics (0.30%).

## Fund documents

- [Fund page at Vanguard](https://www.vanguard.co.uk/professional/product/etf/equity/E153/russell-2000-us-small-cap-ucits-etf-usd-acc)
- [Key investor information document (KIID)](https://fund-docs.vanguard.com/ie000gtbexg4-en.pdf)
- [Factsheet](https://fund-docs.vanguard.com/Russell_2000_U.S._Small-Cap_UCITS_ETF_USD_Acc_E153_EU_INT_UK_EN.pdf)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.